Physician profile
Eric W Smith
NPI 1417910720
$783.78
in general payments reported to CMS, 2019-2025
15 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $210 · 2021: $16.06 · 2023: $23.34 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $209.69 | 2020 | |
| Dexcom, INC. | $111.36 | 2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals Lp | $103.91 | 2025 | Farxiga, Airsupra |
| Lilly USA, LLC | $103.73 | 2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.44 | 2025 | Jardiance |
| Glaxosmithkline, LLC. | $37.66 | 2025 | Shingrix |
| Abiomed | $26.07 | 2025 | |
| Pharmacyclics LLC, An Abbvie Company | $23.34 | 2023 | Epkinly, Imbruvica |
| Corcept Therapeutics | $22.18 | 2025 | Korlym |
| Abbott Laboratories | $21.41 | 2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $19.61 | 2025 | The Cologuard Plus Collection Kit |
| Eisai INC. | $16.06 | 2021 | |
| Novo Nordisk INC | $15.63 | 2025 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.11 | 2025 | Xifaxan |
| Amgen INC. | $13.58 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.